Immuneering Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio404.05204.62
P/B Ratio1.652.381.172.73
Price/Tangible Book1.992.581.252.86
Enterprise Value Ratios
EV/Revenue49.59128.17
Profitability & Returns
Return on Equity (ROE)-0.93%-0.53%-0.38%-0.35%-0.75%
Return on Assets (ROA)-0.52%-0.32%-0.22%-0.21%-0.41%
Return on Capital Employed (ROCE)-1.42%-0.62%-0.45%-0.21%-0.47%
Leverage & Solvency Ratios
Debt/Equity0.100.050.040.030.02
Liquidity Ratios
Current Ratio5.2811.3613.5027.0416.73
Quick Ratio4.8210.9213.1026.5316.66
Efficiency Ratios
Asset Turnover0.000.020.09
Yield & Distribution Ratios
Earnings Yield-0.89%-0.25%-0.39%-0.08%
FCF Yield-0.81%-0.23%-0.35%-0.07%
Buyback Yield-0.06%-0.08%-0.94%-1.75%0.00%